Variable | Univariate analysis | Multivariate analysis | ||||
---|---|---|---|---|---|---|
OR | 95% CI | P | OR | 95% CI | P | |
Age | 1.00 | 0.98–1.03 | 0.772 | |||
Gender: | ||||||
Female | 0.94 | 0.52–1.71 | 0.84 | |||
Male (Ref) | 1 | |||||
T stage: | ||||||
T1 | 3.63 | 1.82–7.20 | < 0.001 | 2.96 | 1.07–8.13 | 0.036 |
T2 | 2.83 | 1.07–7.46 | 0.035 | 2.24 | 0.56–8.90 | 0.25 |
T3 | 1.79 | 0.84–3.85 | 0.134 | |||
T4 (Ref) | 1 | |||||
N stage: | ||||||
N0 | 1.87 | 0.76–4.56 | 0.136 | |||
N1 | 0.90 | 0.42–1.94 | 0.86 | |||
N2 | 0.62 | 0.28–1.36 | 0.24 | |||
N3 (Ref) | 1 | |||||
AJCC Stage: | ||||||
Stage I | 4.2 | 1.67–10.51 | 0.002 | 1.78 | 0.39–8.11 | 0.046 |
Stage II | 2.31 | 1.12–4.76 | 0.023 | 0.75 | 0.23–2.46 | 0.633 |
Stage III | 1.29 | 0.68–2.44 | 0.433 | |||
Stage IV (Ref) | 1 | |||||
Treatment modality: | ||||||
RT alone | 3.12 | 1.45–6.74 | 0.004 | 1.36 | 0.39–4.72 | 0.627 |
ChemoRT | 2.51 | 1.32–4.78 | 0.005 | 2.46 | 0.98–6.16 | 0.054 |
Induction chemo (Ref) | 1 |